Comprehensive Financial Planning »

Denali Therapeutics shares owned by Comprehensive Financial Planning

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Comprehensive Financial Planning from 13F filings

Historical chart of Comprehensive Financial Planning investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Comprehensive Financial Planning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Comprehensive Financial Planning

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.3k 200 16.51

More positions owned by Comprehensive Financial Planning

Janus Henderson Aaa Clo Etf Uie (JAAA)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Invsc S P 500 Top 50 Etf Uie (XLG)
Vanguard S&p 500 Etf Uie (VOO)
Facebook Inc cl a (META)
Ishares Core S&p 500 Etf Uie (IVV)
Jpmorgan Active Growth Etf Uie (JGRO)
Amazon (AMZN)
T Rowe Price Blue Chip Growth Etf Uie (TCHP)
Spdr S&p 500 Etf Uie (SPY)
Ishares S&p 500 Growth Etf Uie (IVW)
Listed Fnds Rondhl Mgnfcnt Etf Uie (MAGS)
Wisdomtree Us Qlt Div Grw Etf Uie (DGRW)

View all positions for Comprehensive Financial Planning

Top funds holding Denali Therapeutics

Vanguard Group
BlackRock
Baillie Gifford & Co
T. Rowe Price Investment Management
FMR
State Street Corporation
Temasek Holdings
Norges Bank Investment Management
Ubs Global Asset Management Americas
Goldman Sachs Group
Baker Bros. Advisors
Capital Research Global Investors
Alliancebernstein
Geode Capital Management
Holocene Advisors

View all funds holding Denali Therapeutics